Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Anika Therapeutics Inc (NASDAQ:ANIK)

47.24
Delayed Data
As of 4:00pm ET
 -0.21 / -0.44%
Today’s Change
30.93
Today|||52-Week Range
54.96
+23.79%
Year-to-Date
Rigel (RIGL) Stock Up on Positive Phase III Fostamatinib Data
8:52am / Zacks.com - Paid Partner Content
Xenetic's IND to Start Phase II Virexxa Study Accepted in U.S.
Aug 22 / Zacks.com - Paid Partner Content
Alexion's GVHD Candidate Gets Orphan Drug Status in the EU
Aug 30 / Zacks.com - Paid Partner Content
Portola IndexXa's Regulatory Application Validated in the EU
Aug 22 / Zacks.com - Paid Partner Content
Amgen (AMGN) Reports Positive Data on Prolia and Repatha
Aug 30 / Zacks.com - Paid Partner Content
Teva Cinqaero Gets EU Nod for Severe Eosinophilic Asthma
Aug 19 / Zacks.com - Paid Partner Content
CTI BioPharma Reports Mixed Pacritinib Study Data, Stock Up
Aug 30 / Zacks.com - Paid Partner Content
Aclaris (ACRS) Common Warts Candidate Positive in Phase II
Aug 19 / Zacks.com - Paid Partner Content
Macrocure Stock Up on Merger Deal with Leap Therapeutics
Aug 30 / Zacks.com - Paid Partner Content
FDA OKs Edwards Lifesciences' Sapien 3 for Extended Use
Aug 19 / Zacks.com - Paid Partner Content
Weakness Seen in Keryx Biopharmaceuticals (KERX) Estimates: Should You Stay Away?
Aug 29 / Zacks.com - Paid Partner Content
Why You Shouldn't Bet Against Anika Therapeutics (ANIK) Stock
Aug 17 / Zacks.com - Paid Partner Content
Illumina Keen on Genome Network Growth & Global Expansion
Aug 26 / Zacks.com - Paid Partner Content
Inovio (INO) Veterinary Vaccine Rights Licensed to Plumbline
Aug 17 / Zacks.com - Paid Partner Content
Vanda Pharmaceuticals (VNDA) Catches Eye: Stocks Up 20%
Aug 26 / Zacks.com - Paid Partner Content
Radius (RDUS) Osteoporosis Drug Positive in Phase III Study
Aug 17 / Zacks.com - Paid Partner Content
Amgen Gets CRL for Secondary Hyperparathyroidism Drug
Aug 25 / Zacks.com - Paid Partner Content
Actelion (ALIOF) Uptravi Approved for PAH in Switzerland
Aug 17 / Zacks.com - Paid Partner Content
Gilead (GILD) Truvada Gets EU Approval for Label Expansion
Aug 23 / Zacks.com - Paid Partner Content